300347.SZ
泰格医药
SZSE · Healthcare · M 科研服务 · CN
CNY 49.16
−9.58%Margins
Gross margin
26.6%
EBITDA margin
17.9%
EBIT margin
18.0%
Net margin
10.9%
FCF margin
14.4%
3.7%
Return on equity
2.7%
Return on assets
5.7%
Return on invested capital
0.25x
Asset turnover
CNY 1.2B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026